Featured
Another Country Boss departs
After 11 years working for the same Big Pharma and almost four serving on the Board of the industry body, this executive is the latest leadership departure
Regulatory & Reimbursement
Who's won an October PBS listing... already?
Nineteen days before the turn of the calendar, the Govt has announced the PBS listing of a new treatment for patients with a debilitating disease
Industry & Companies
'Defining moment' for Sydney viral vector facility
TGA grants licence to manufacture therapeutic goods, marking a significant milestone for the company and sovereign capability for Australia
Leadership & People
How to lead without the job title
Medical affairs heavyweights joined a panel at MAPA to outline how people can take the lead in their organisations whatever the title they have
Jobs & Workplace
Global boss lands top Aussie role
Relocating to Australia from London, this global value and access high-flyer has been snapped up by J&J for a senior leadership position
Featured
Butler tips more drugs to follow the 'Beast’
The Health Minister is “very confident” that other immunotherapy drug makers will submit broad PBS listing submissions following in the footsteps of a drug he referred to as the 'Beast' which has just won multi-cancer reimbursement
Industry & Companies
Company eyes ‘golden decade’
Pharma sets an ambitious goal to establish a portfolio of more than 100 biosimilars by 2040, up substantially from the 13 it currently markets
Industry & Companies
Industry body names new leader
After 12 years, this well-known leader who has worked tirelessly for equity in cancer care is standing down with a successor already named
Industry & Companies
MAPA Summit unpacks leadership in the age of AI
The MAPA Medical Affairs Summit is preparing attendees for the way AI will change their roles, underlining how important it is that they exert influence independent of their job title
Industry & Companies
On the edge: Here comes the $550B cliff fall
An industry-wide upheaval is coming to pharma with a monster patent cliff fall to hit in the next four years and even one of the world's newest blockbusters is not safe
Jobs & Workplace
Open: Netflix-style library for Medical Affairs
The new resource is a living, curated repository bringing the growing evidence base around the medical affairs function together in one place - and its free
Industry & Companies
Pharma backs Australia’s World Cup campaign
A company has announced its sponsorship of the Poweroos, saying the partnership reflects a broader commitment to supporting people living with rare and neuromuscular conditions
Featured
Meet ANZ's best Medical Affairs professionals
Thirteen medical affairs professionals, some representing their teams, have been recognised for their outstanding contribution to the industry across Australia and New Zealand
Latest
Where does your State rank on patient support?
Australian States and Territories have been ranked on how well they support families who are getting treatment for cancer, and only one passed muster.
Industry & Companies
Patients pick best pharma but there's a problem
When it comes to favourite pharmas, one company is a clear standout according to this patient cohort which says industry's overall corporate reputation has improved... except in one crucial area
Leadership & People
Butler sidesteps 'future PM' speculation
Minister deftly sidesteps questions about growing speculation he is the Labor Party's "leader-in-waiting" when Anthony Albanese's time as PM comes to an end
Regulatory & Reimbursement
Call for accelerated rare cancers pathway
Rare Cancers Australia is calling for a raft of reforms, including reducing the median time from TGA approval of a medicine to PBS listing from 639 days to just 60
Regulatory & Reimbursement
Company takes second tilt at a PBAC 'Yes'
The agenda for the November PBAC meeting has been updated with one company rejected in July making quick work of trying again
Regulatory & Reimbursement
TGA approval lands in the nick of time
A new asthma treatment set to be considered for PBS funding at the PBAC's intracycle meeting this month has been approved for use in Australia
Jobs & Workplace
Pharma bosses call out work-life balance
Two senior pharma executives - one a former Aussie GM - have called out perfect work-life balance as an unrealistic expectation placed on the industry
Jobs
Regulatory & Reimbursement
PBS election sweetener pays off for voters
New figures released by the Department of Health shows more than one million women have accessed newly PBS listed medicines since March 2025
Industry & Companies
GM says Australia cannot afford to fall behind
The BMS Patient & Parliament Summit will be held in Canberra today with urgent action needed for patients who fear they won't survive the wait for treatment
Jobs & Workplace
Redundancies hit pharma spin-off
Jobs have been cut following a recent field force review with changes made to ensure the company's customer coverage model reflects an evolving market
Regulation & Legal
Which specialists are embracing AI?
A survey including Australian doctors has revealed which HCPs have the highest trust in AI tools - and which specialties are not AI fans as the TGA investigates regulations in the space
Jobs & Workplace
Pharma promotes exec to Country Lead
High-flyer has been promoted to Country Lead, taking responsibility for heading the company's innovative medicines business in Australia
Regulatory & Reimbursement
Medicine moves to OTC to ease access issues
A previously prescription-only drug has hit the shelves as a pharmacy drug, with the hope it will increase awareness of the ability to treat symptoms
- Jobs & Workplace Who's cracked America’s Best Companies list?
- Jobs & Workplace Sydney exec lands GM role overseas
- Other News Does Aussie pharma pass the Pub Test?
- Regulatory & Reimbursement Double or nothing: Unlocking access to new drugs
- Regulatory & Reimbursement This drug won a standing ovation but will Aussies ever see it?
- Industry & Companies ACCC approves $68 billion acquisition
- Regulatory & Reimbursement Another domino falls for drug in TGA probe
- Regulatory & Reimbursement BMS notches a first with TGA tick
- Jobs & Workplace Big Pharma picks Sydney CBD for new HQ
- Leadership & People Who’s up for a 2026 PRIME Award?
